| 2020 |
Pan KS, de Castro LF, Roszko KL, Greenberg ED, FitzGibbon EJ, Dufresne CR, Boyce AM, Collins MT. Successful intravascular treatment of an intraosseous arteriovenous fistula in fibrous dysplasia. Calcif Tiss Int. August 2020;107(2):195-200. |
0 |
0 |
| 2021 |
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tiss Int. January 2021;108(1):128-142. |
3 |
2 |
| 2021 |
Roszko KL, Brown S, Pang Y, Huynh T, Zhuang Z, Pacak K, Collins MT. C‐terminal, but not intact, FGF23 and EPO are strongly correlatively elevated in patients with gain‐of‐function mutations in HIF2A: clinical evidence for EPO regulating FGF23. J Bone Miner Res. February 2021;36(2):315-321. |
2 |
1 |
| 2022 |
Roszko KL, Hu TY, Guthrie LC, Brillante BA, Smith M, Collins MT, Gafni RI. PTH 1-34 replacement therapy has minimal effect on quality of life in patients with hypoparathyroidism. J Bone Miner Res. January 2022;37(1):68-77. |
1 |
0 |
| 2022 |
Roszko KL, Smith LMS, Sridhar AV, Roberts MS, Hartley IR, Gafni RI, Collins MT, Fox JC, Nemeth EF. Autosomal dominant hypocalcemia type 1: a systematic review. J Bone Miner Res. October 2022;37(10):1926-1935. |
0 |
0 |
| 2022 |
Hartley IR, Gafni RI, Roszko KL, Brown SM, de Castro LF, Saikali A, Ferreira CR, Gahl WA, Pacak K, Blau JE, Boyce AM, Salusky IB, Collins MT, Florenzano P. Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia. J Bone Miner Res. November 2022;37(11):2174-2185. |
0 |
0 |
| 2022 |
Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV, Xia W, Brandi M-L. Hypoparathyroidism: genetics and diagnosis. J Bone Miner Res. December 2022;37(12):2615-2629. |
4 |
1 |
| 2023 |
Roszko KL, Guthrie L, Li X, Collins MT, de Castro LF, Boyce AM. Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia/McCune Albright syndrome. J Bone Miner Res. March 2023;38(3):443-450. |
0 |
0 |